Propagation characteristics of dust acoustic (DA) solitons in an opposite polarity dusty plasma medium containing inertial positive and negative dust grains and inertialess ions and electrons following Maxwellian distribution have been theoretically investigated by taking the effect of generalized polarization force into consideration. By using the reductive perturbation method, the Korteweg–de Vries equation that governs the nonlinear dust acoustic waves has been derived. It has been found that rarefactive and compressive solitons (solitons associated with negative and positive potentials) propagate in such a dusty plasma medium. The dependence of soliton characteristics on the system parameters has been discussed. It is observed that the basic properties of the DA solitons are significantly modified by the effects of generalized polarization force, ion-to-electron temperature ratio, and positive dust component. The findings of this investigation may be used in understanding the wave propagation in space and laboratory plasmas in which dust of opposite polarity coexists under the polarization force.
Within the framework of inverse diffractive optics, we present a design for diffractive axicons in twisted, spatially partially coherent fields, in particular twisted Gaussian Schell-model (TGSM) fields. The design is based on the method of stationary phase. A general modification is introduced to the inverse diffractive optics approach for improving the synthesized optical element to produce the desired intensity distribution. Both the design and modification are demonstrated with annular-aperture axicons generating uniform-intensity axial line segments in partially coherent TGSM illumination.
We present experimental evidence for coherent, directional emission from a random gain medium above the threshold for laserlike emission. In particular, we report the first observation (to our knowledge) of a coherent angular backscattering peak above this threshold. A plausible explanation of our findings follows from the assumption that superfluorescent emission occurs in the gain medium above threshold.
BACKGROUND AND OBJECTIVESNo data are available in Saudi Arabia on the relationship between coronary artery calcification (CAC) and myocardial perfusion scintigraphy (MPS) in asymptomatic women, for determining subclinical coronary artery disease (CAD). The main objective of this study was to investigate the relationship between the presence of CAC and stress-induced myocardial ischemia by MPS in asymptomatic women.DESIGN AND SETTINGSingle-center retrospective study over a 2-year period.METHODSOne hundred and one women (mean [SD] age, 56 [11] years) without known CAD underwent both MPS and CAC scanning within 3 months. The frequency of ischemia by MPS was compared with the presence or absence of CAC and the number of CAD risk factors.RESULTSThe prevalence of ischemic MPS was 22% (22/101). Among the 22 patients with ischemic MPS, the CAC score was 0 in 5 patients of 22 (23%), 1 to 200 in 4 patients of 22 (18%), and more than 200 in 13 patients of 22 (59%) (P=.0001). In contrast, among the 79 patients with normal MPS, the CAC score was 0 in 44 of 79 (56%) patients, 1 to 200 in 25 of 79 (32%), and more than 200 in 10 of 79 (13%). The presence or absence of CAC was the single most important predictor of the MPS result (P=.0001).CONCLUSIONSModerate to severe CAC is associated with ischemic MPS in more than 50% of asymptomatic women with 2 or more CAD risk factors. Abnormal MPS is rarely associated with a 0 CAC score. Normal MPS does not exclude subclinical CAD. Therefore, CAC screening is an appropriate initial screening test for CAD in asymptomatic women.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.